Scailyte Alternatives & Competitors
12 companies similar to Scailyte — True precision medicine through single-cell science.
Companies similar to Scailyte
radiomics.bio
Radiomics, Deep Learning & Federated Learning for AI powered drug development trajectory a...
Paratus Sciences
Translating evolutionary insights into first-in-class medicines
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
Syntekabio Inc.
AI Platform for Drug Discovery & Precision Medicine (226330:KOSDAQ)
Rival Readout
Competing with Scailyte? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Celldom, Inc.
Find and study cells that make diseases incurable
Genialis
Know your patient, know your drug
Lynx Biosciences, Inc.
Resolving cancer biology through integrated multi-omics.
Mission Bio
The Tapestri® Platform; the only technology that provides single-cell targeted DNA sequenc...
Navignostics AG
Finding the Right Drug for Each Patient
Rubedo Life Sciences
Medicines to keep you biologically young by targeting the pathological cells that drive ch...
Ikena Oncology (Merged with ImageneBio)
Ikena merged with ImageneBio on in July 2025. Please visit https://inmagenebio.com/ for mo...
Multiomic Health
AI-Enabled Precision Medicine for Cardiovascular Renal Metabolic (CRM) Disease
About Scailyte
Scailyte, founded in 2017 and headquartered in Basel, Switzerland, is a leader in AI-driven biomarker discovery from single-cell omics data. The company’s proprietary AI platform, ScaiVision, enables the analysis of over 60 million single-cell profiles. This capability positions Scailyte at the forefront of developing...
Autoimmune Foundation Model development, Advanced patient endotyping, Predictive disease modeling, Biomarker assays co-development, Pharma partnership facilitation
Pharmaceutical companies, Biotech firms, Clinical researchers, Healthcare providers, Decision-makers in precision medicine
AI-driven Biomarker Discovery, Single-cell Omics, ScaiVision Platform, Oncology, Auto-immunity, Precision Medicine, Biomarker Signatures, Clinical Partnerships, Biotech Collaboration, Pharma Collaboration, Drug Development, Phenotypic Biomarker Discovery, Molecular Profiles, Disease Biology
B2B, SaaS, Platform
Service Fee, Subscription, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Scailyte: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Scailyte on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.